These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36038088)

  • 21. Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19.
    Singh AK; Singh R
    Diabetes Res Clin Pract; 2020 Sep; 167():108382. PubMed ID: 32853686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
    Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Environmental pollution and COVID-19: the molecular terms and predominant disease outcomes of their sweetheart agreement.
    Colacci A; Bortone G; Maffei G; Marchesi S; Mescoli A; Parmagnani F; Pillo G; Ranzi A; Rotondo F; Serra S; Vaccari M; Zauli Sajani S; Mascolo MG; Jacobs MN
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):169-182. PubMed ID: 33412808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective action of natural and induced immunization against the occurrence of delta or alpha variants of SARS-CoV-2 infection: a test-negative case-control study.
    Corrao G; Franchi M; Rea F; Cereda D; Barone A; Borriello CR; Della Valle PG; Ercolanoni M; Fortino I; Jara J; Leoni O; Mazziotta F; Pierini E; Preziosi G; Tirani M; Galli M; Bertolaso G; Pavesi G; Bortolan F
    BMC Med; 2022 Feb; 20(1):52. PubMed ID: 35130877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era.
    Ceriello A; Standl E; Catrinoiu D; Itzhak B; Lalic NM; Rahelic D; Schnell O; Škrha J; Valensi P;
    Diabetes Care; 2020 Jul; 43(7):1427-1432. PubMed ID: 32409501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 Infection and Hospitalization Among Adults Aged ≥18 Years, by Vaccination Status, Before and During SARS-CoV-2 B.1.1.529 (Omicron) Variant Predominance - Los Angeles County, California, November 7, 2021-January 8, 2022.
    Danza P; Koo TH; Haddix M; Fisher R; Traub E; OYong K; Balter S
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(5):177-181. PubMed ID: 35113851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of diabetes on short-term mortality and incidence of first hospitalizations for cardiovascular events after recovery from SARS-CoV-2 infection.
    Profili F; Seghieri G; Francesconi P
    Diabetes Res Clin Pract; 2022 May; 187():109872. PubMed ID: 35429573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of SARS-CoV-2 Antibodies in Children and Adults with Type 1 Diabetes.
    Jia X; Gesualdo P; Geno Rasmussen C; Alkanani AA; He L; Dong F; Rewers MJ; Michels AW; Yu L
    Diabetes Technol Ther; 2021 Jul; 23(7):517-521. PubMed ID: 33544017
    [No Abstract]   [Full Text] [Related]  

  • 30. Going viral in the islet: mediators of SARS-CoV-2 entry beyond ACE2.
    Rangu R; Wander PL; Barrow BM; Zraika S
    J Mol Endocrinol; 2022 Jun; 69(2):R63-R79. PubMed ID: 35521990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Awareness of SARS-CoV-2 Omicron Variant Infection Among Adults With Recent COVID-19 Seropositivity.
    Joung SY; Ebinger JE; Sun N; Liu Y; Wu M; Tang AB; Prostko JC; Frias EC; Stewart JL; Sobhani K; Cheng S
    JAMA Netw Open; 2022 Aug; 5(8):e2227241. PubMed ID: 35976645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico.
    Martos-Benítez FD; Soler-Morejón CD; García-Del Barco D
    Intern Emerg Med; 2021 Sep; 16(6):1507-1517. PubMed ID: 33411264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the Performance of the PanBio COVID-19 Antigen Test in SARS-CoV-2 B.1.1.7 (Alpha) Variants versus non-B.1.1.7 Variants.
    van Ogtrop ML; van de Laar TJW; Eggink D; Vanhommerig JW; van der Reijden WA
    Microbiol Spectr; 2021 Dec; 9(3):e0088421. PubMed ID: 34817226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcomes in patients infected with different SARS-CoV-2 variants at one hospital during three phases of the COVID-19 epidemic in Marseille, France.
    Hoang VT; Colson P; Levasseur A; Delerce J; Lagier JC; Parola P; Million M; Fournier PE; Raoult D; Gautret P
    Infect Genet Evol; 2021 Nov; 95():105092. PubMed ID: 34571275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants.
    Chakraborty C; Sharma AR; Bhattacharya M; Agoramoorthy G; Lee SS
    mBio; 2021 Aug; 12(4):e0114021. PubMed ID: 34465019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type 1 diabetes mellitus and SARS-CoV-2 in pediatric and adult patients - Data from the DPV network.
    Büttner BR; Tittel SR; Kamrath C; Karges B; Köstner K; Melmer A; Müller-Roßberg E; Richter F; Rohrer TR; Holl RW
    J Diabetes; 2022 Nov; 14(11):758-766. PubMed ID: 36443963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of Vaccine Breakthrough SARS-CoV-2 Infection and Associated Factors in Healthcare Workers of Trieste Teaching Hospitals (North-Eastern Italy).
    Basso P; Negro C; Cegolon L; Larese Filon F
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215930
    [No Abstract]   [Full Text] [Related]  

  • 38. Has Omicron Changed the Evolution of the Pandemic?
    Lundberg AL; Lorenzo-Redondo R; Ozer EA; Hawkins CA; Hultquist JF; Welch SB; Prasad PVV; Oehmke JF; Achenbach CJ; Murphy RL; White JI; Havey RJ; Post LA
    JMIR Public Health Surveill; 2022 Jan; 8(1):e35763. PubMed ID: 35072638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of the SARS-CoV-2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission.
    Shrestha LB; Foster C; Rawlinson W; Tedla N; Bull RA
    Rev Med Virol; 2022 Sep; 32(5):e2381. PubMed ID: 35856385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Emergence of SARS-CoV-2 Variant(s) and Its Impact on the Prevalence of COVID-19 Cases in the Nabatieh Region, Lebanon.
    Noureddine FY; Chakkour M; El Roz A; Reda J; Al Sahily R; Assi A; Joma M; Salami H; Hashem SJ; Harb B; Salami A; Ghssein G
    Med Sci (Basel); 2021 Jun; 9(2):. PubMed ID: 34199617
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.